Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 5/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.39 |
| ▸ | CA12 | O43570 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | CA9 | Q16790 | 1/20 | 0.39 |
| ▸ | GBA1 | P04062 | 1/20 | 0.37 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.37 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.37 |
| ▸ | KDM5A | P29375 | 2/20 | 0.36 |
| ▸ | PHF8 | Q9UPP1 | 2/20 | 0.36 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.36 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8378583 | 1.00 | DNM1 (0.50) | DNM1TSHRTHRBKCNH2CA12 | |
| SCHEMBL8374808 | 1.00 | DNM1 (0.50) | DNM1TSHRTHRBKCNH2CA12 | |
| SCHEMBL8379915 | 1.00 | DNM1 (0.50) | DNM1TSHRTHRBKCNH2CA12 | |
| SCHEMBL290988 | 1.00 | DNM1 (0.50) | DNM1TSHRTHRBKCNH2CA12 | |
| SCHEMBL3248572 | 1.00 | DNM1 (0.50) | DNM1TSHRTHRBKCNH2CA12 | |
| SCHEMBL8374761 | 1.00 | DNM1 (0.50) | DNM1TSHRTHRBKCNH2CA12 | |
| SCHEMBL8375294 | 1.00 | DNM1 (0.50) | DNM1TSHRTHRBKCNH2CA12 | |
| SCHEMBL8375333 | 1.00 | DNM1 (0.50) | DNM1TSHRTHRBKCNH2CA12 | |
| SCHEMBL8376140 | 1.00 | DNM1 (0.50) | DNM1TSHRTHRBKCNH2CA12 | |
| SCHEMBL8374768 | 1.00 | DNM1 (0.50) | DNM1TSHRTHRBKCNH2CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 190 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6111045-A | YIELDS A VULCANIZED RUBBER SHOWING IMPROVEMENTS IN HEAT BUILD-UP, TENSILE STRENGTH, ABRASION RESISTANCE AND PROCESSABILITY | NIPPON ZEON CO. LTD. (JP) | 2000-08-29 | — | — | US | claimed |
| EP-0092830-A2 | Cephalosporin derivatives, process for their preparation, pharmaceutical compositions containing them and their application | CIBA-GEIGY AG (CH) | 1983-11-02 | — | — | EP | claimed |
| CN-110183979-B | Multilayer composite film and use thereof | 江苏穿越光电科技有限公司 | 2024-05-14 | — | — | CN | disclosed |
| EP-4355794-A1 | FREE-RADICALLY POLYMERIZABLE COPOLYMER, FREE-RADICALLY POLYMERIZABLE COMPOSITION CONTAINING THE SAME, AND POLYMERIZED REACTION PRODUCT THEREFROM | 3M Innovative Properties Company (US) | 2024-04-24 | — | — | EP | disclosed |
| CN-117500849-A | Free radically polymerizable copolymer, free radically polymerizable composition comprising same, and polymerization reaction product therefrom | 3M创新有限公司 | 2024-02-02 | — | — | CN | disclosed |
| US-20230157952-A1 | METHOD FOR IMPROVING THE STABILITY OF A PHARMACEUTICAL COMPOSITION COMPRISING A HIGH PENETRATION DRUG, AND THE PHARMACEUTICAL COMPOSITION OBTAINED THEREFROM | TECHFIELDS INC. (US) | 2023-05-25 | — | — | US | disclosed |
| WO-2022263987-A1 | FREE-RADICALLY POLYMERIZABLE COPOLYMER, FREE-RADICALLY POLYMERIZABLE COMPOSITION CONTAINING THE SAME, AND POLYMERIZED REACTION PRODUCT THEREFROM | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2022-12-22 | — | — | WO | disclosed |
| CN-115484984-A | Method for improving stability of pharmaceutical composition comprising high penetration drug and pharmaceutical composition obtained thereby | 于崇曦 | 2022-12-16 | — | — | CN | disclosed |
| EP-3269747-B1 | ANTITHROMBOTIC BLOCK COPOLYMER | UNIV YAMAGATA NAT UNIV CORP (JP) | 2021-10-20 | — | — | EP | disclosed |
| EP-3851489-A1 | MODIFIED MULTI-COMPONENT COPOLYMER, RUBBER COMPOSITION, RESIN COMPOSITION, TIRE AND RESIN PRODUCT | BRIDGESTONE CORPORATION (JP) | 2021-07-21 | — | — | EP | disclosed |
| CN-111370563-A | Composite fluorescent glue film and application thereof | 弗洛里光电材料（苏州）有限公司 | 2020-07-03 | — | — | CN | disclosed |
| EP-0328024-A1 | Tetramethylpiperidino-s triazines | CIBA-GEIGY AG (CH) | 1989-08-16 | — | — | EP | disclosed |
| US-4831026-A | ANTIBIOTICS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1989-05-16 | — | — | US | disclosed |
| EP-0215435-A1 | 2-Oxa-isocephem compounds, compositions containing same and processes for preparing same | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1987-03-25 | — | — | EP | disclosed |
| EP-0092830-A2 | Cephalosporin derivatives, process for their preparation, pharmaceutical compositions containing them and their application | CIBA-GEIGY AG (CH) | 1983-11-02 | — | — | EP | disclosed |
| US-4388448-A | ANIONIC INITIATOR | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1983-06-14 | — | — | US | disclosed |
| US-4351924-A | USING A REACTION PRODUCT OF AN ORGANO ALKALI METAL ACETAL OR KETAL AND 1,1-DIPHENYLETHYLENE; AUTOMOBILE POWDER COATINGS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1982-09-28 | — | — | US | disclosed |
| EP-0055728-A4 | HYDROPHILIC INTERPOLYMERS OF ACRYLIC ACID AND AN ACRYLATE. | GOODRICH CO B F (US) | 1982-08-11 | — | — | EP | disclosed |
| EP-0055728-A1 | HYDROPHILIC INTERPOLYMERS OF ACRYLIC ACID AND AN ACRYLATE | The B.F. GOODRICH Company (US) | 1982-07-14 | — | — | EP | disclosed |
| WO-1982000147-A1 | HYDROPHILIC INTERPOLYMERS OF ACRYLIC ACID AND AN ACRYLATE | GOODRICH CO B F (US) | 1982-01-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230157952-A1 | METHOD FOR IMPROVING THE STABILITY OF A PHARMACEUTICAL COMPOSITION COMPRISING A HIGH PENETRATION DRUG, AND THE PHARMACEUTICAL COMPOSITION OBTAINED THEREFROM | SLC7A1, ABCG2, SLCO4C1 | DNM1 1055/4885TSHR 4222/4885THRB 4835/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.